LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode
(2025) Angewandte Chemie (International Edition) — Vol. 64, n° 19, p. e202500518 (2025)
Files
AngewChem_Mazharietal_Revisedversion.docx
Open Access - Microsoft Word XML
- 2.43 MB
Details
- Authors
- Abstract
- Lipid metabolism is essential for cellular homeostasis, and its disruption is linked to various diseases. Acyl-coenzyme A synthetase long-chain family member 4 (ACSL4), a pivotal enzyme in lipid metabolism, has emerged as a therapeutic target for ferroptosis-related conditions and cancer. Antidiabetic drug rosiglitazone is the reference ACSL4 inhibitor. However, its potent activity on peroxisome proliferator-activated receptor gamma (PPARγ), a key regulator of lipid metabolism, represents a significant limitation. Here, we report the discovery and characterization of LIBX-A401 (compound 9), a potent ACSL4 inhibitor derived from rosiglitazone but devoid of PPARγ activity. We showed that its binding to ACSL4 is ATP-dependent. Using Hydrogen-Deuterium Exchange Mass Spectrometry, we demonstrate that ATP binding stabilizes the ACSL4 C-terminus, with LIBX-A401 further stabilizing this domain and altering the fatty acid gate region. Photoaffinity labeling with a diazirine probe identified A329 within the fatty acid binding site, while molecular dynamics simulations and mutagenesis highlighted Q302 as critical for LIBX-A401 binding. LIBX-A401 exhibits significant anti-ferroptotic properties in cells, supported by demonstrated target engagement. These findings position LIBX-A401 as a valuable tool for studying ACSL4 in ferroptosis-related diseases and cancer, while its elucidated binding mode paves the way to the rational design of improved ACSL4 inhibitors with therapeutic potential.
- Affiliations
Citations
Mazhari Dorooee, D., Ravez, S., Vertommen, D., Renault, N., Papadopoulos, N., Marteau, R., Charnelle, E., Porte, K., Gobert, A., Hennuyer, N., Herinckx, G., Pautric, M., Jonneaux, A., Devedjian, J.-C., Devos, D., Staels, B., Melnyk, P., Constantinescu, S., Frédérick, R., & El Bakali, J. (2025). LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode. Angewandte Chemie (International Edition), 64(19), e202500518. https://doi.org/10.1002/anie.202500518 (Original work published 2025)